General
Preferred name
RAVUCONAZOLE
Synonyms
BMS-207147 ()
ER-30346 ()
Ravuconazol ()
P&D ID
PD017394
CAS
182760-06-1
Tags
available
drug candidate
Drug Status
investigational
Max Phase
2.0
Drug indication
fungal infectious disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ravuconazole (BMS-207147;ER-30346) is an orally available triazole antifungle agent that potently inhibits a wide range of fungi.
PRICE
52
DESCRIPTION
Ravuconazole (ER-30346) is a potent triazole antifungal that potently inhibits a wide range of fungi.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
8
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
MedChem Express Bioactive Compound Library
Pandemic Response Box
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
437.11
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
4
cLogP
4.24
TPSA
87.62
Fraction CSP3
0.18
Chiral centers
2.0
Largest ring
6.0
QED
0.49
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Microbiology/virology
Anti-infection
MOA
sterol demethylase inhibitor
Target
Fungal
Antifungal
Source data
